Hemostasis is defined as "the blocking of bleeding or bleeding through blood vessels or other parts of the body".Hemostatic agents and tissue adhesives are used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.The industry is driven by a growing base of older people and an increase in the prevalence of chronic diseases.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.Chronic diseases eventually lead to surgery for patients, which in turn promotes the development of the hemostasis and tissue sealant industries.
According to our (Global Info Research) latest study, the global Hemostatic and Tissue Sealing Agents market size was valued at USD 2882.9 million in 2022 and is forecast to a readjusted size of USD 3514.7 million by 2029 with a CAGR of 2.9% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Hemostatic and Tissue Sealing Agents key players include J&J, Baxter, C R Bard, etc. Global top three manufacturers hold a share over 45%.
North America is the largest market, with a share about 60%, followed by China, and Europe, both have a share about 30 percent.
In terms of product, Hemostatic is the largest segment, with a share about 75%. And in terms of application, the largest application is General Surgery, followed by Minimally Invasive Surgery, etc.
This report is a detailed and comprehensive analysis for global Hemostatic and Tissue Sealing Agents market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Hemostatic and Tissue Sealing Agents market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Hemostatic and Tissue Sealing Agents market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Hemostatic and Tissue Sealing Agents market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Hemostatic and Tissue Sealing Agents market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hemostatic and Tissue Sealing Agents
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hemostatic and Tissue Sealing Agents market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include J&J, Baxter, C R Bard, B Braun and Integra Life Sciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Hemostatic and Tissue Sealing Agents market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Hemostatic
Sealant Gum
Market segment by Application
Minimally Invasive Surgery
General Surgery
Other
Major players covered
J&J
Baxter
C R Bard
B Braun
Integra Life Sciences
Advance Medical Solution
CSL Behring
CryoLife
Zimmer Biomet
Pfizer
Medtronic
Smith & Nephew
Cohera Medical
Shanghai Haohai Biological Technology Co. Ltd.
Shandong Saikesaisi Biotechnology Co., Ltd
Chang ShaHai Run biological technology Co, LTD
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hemostatic and Tissue Sealing Agents product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Hemostatic and Tissue Sealing Agents, with price, sales, revenue and global market share of Hemostatic and Tissue Sealing Agents from 2018 to 2023.
Chapter 3, the Hemostatic and Tissue Sealing Agents competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hemostatic and Tissue Sealing Agents breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Hemostatic and Tissue Sealing Agents market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Hemostatic and Tissue Sealing Agents.
Chapter 14 and 15, to describe Hemostatic and Tissue Sealing Agents sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Hemostatic and Tissue Sealing Agents. Industry analysis & Market Report on Hemostatic and Tissue Sealing Agents is a syndicated market report, published as Global Hemostatic and Tissue Sealing Agents Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Hemostatic and Tissue Sealing Agents market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.